49739-41-5 Usage
Derivative of
1,2,5-oxadiazole
Contains
a. Sulfonyl group
b. Methyl group
Applications
a. Building block in the synthesis of organic compounds
b. Building block in the synthesis of pharmaceutical compounds
Known for
a. Potential biological activities
b. Antibacterial properties
c. Antifungal properties
Studied for
a. Development of novel drug molecules
Industrial and medicinal implications
Important
These properties and specific content provide a comprehensive overview of 1,2,5-Oxadiazole, 3-methyl-4-(phenylsulfonyl)-, 2-oxide, highlighting its molecular structure, functional groups, applications, and potential for further research and development in the pharmaceutical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 49739-41-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,9,7,3 and 9 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 49739-41:
(7*4)+(6*9)+(5*7)+(4*3)+(3*9)+(2*4)+(1*1)=165
165 % 10 = 5
So 49739-41-5 is a valid CAS Registry Number.
49739-41-5Relevant articles and documents
Pharmacochemistry of the furoxan ring: Recent developments
Calvino,Di Stilo,Fruttero,Gasco,Sorba,Gasco
, p. 321 - 334 (2007/10/02)
In the present work recent results obtained in the pharmacochemistry of the furoxan system are reported. In particular, after a brief description of the salient points of the furoxan chemistry, the synthesis and the properties of a series of Nifedipine and Prazosin analogues, containing this heterocyclic system, are described. Since we observed that a few furoxan derivatives are able to elicit both a dose-dependent rise in platelet cGMP levels and to promote a dose-dependent inhibition of AA-induced [Ca++] rise, and that many substituted furoxans show potent vasodilating and antiaggregatory activity, the possibility of using the furoxan system as a lead in the design of new vasodilators is also discussed.
Unsymmetrically substituted furoxans. III. Methylnitrofuroxan: its structure and behavior toward nucleophilic substitution
Gasco,Mortarini,Rua,Serafino
, p. 587 - 590 (2007/10/08)
-
